Alzamend Neuro (ALZN) Return on Equity [ROE] (2021 - 2026)
Alzamend Neuro (ALZN) reported Return on Equity [ROE] of -278.39% for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 144.30 percentage points from -134.09% a year earlier but up 319.82 percentage points from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2026 (ended Apr 30, 2026), Alzamend Neuro posted Return on Equity [ROE] of -373.18%, up 283.99 percentage points from FY2025.
- Return on Equity [ROE] has a five-year change of -13.75 percentage points (FY2021 to FY2026).
- By fiscal year, Return on Equity [ROE] came in at -657.17% in FY2025 (+3751.14 pp), -4408.31% in FY2024 (-4226.83 pp), -181.47% in FY2023 (-20.50 pp) and -160.97% in FY2022 (+198.46 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -1048.13% in fiscal Q1 2024 and a high of -58.84% in fiscal Q2 2022.
- Year over year, Return on Equity [ROE] has now declined in each of the last three quarters, with an average year-over-year change of -94.55 percentage points over the last four quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was fiscal Q4 2022 (a gain of 1323.30 percentage points); the low point was fiscal Q1 2024 (a drop of 941.47 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -598.22% (Q4 2026), -214.23% (Q3 2026) and -121.06% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Alzamend Neuro | 8.35 Mn | 8.35 Mn | - | -278.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -278.39% |
| Apr 30, 2026 | -598.22% |
| Jan 31, 2026 | -214.23% |
| Oct 31, 2025 | -121.06% |
| Jul 31, 2025 | -134.09% |
| Apr 30, 2025 | -121.73% |
| Jan 31, 2025 | -117.37% |
| Oct 31, 2024 | -460.51% |
| Jul 31, 2023 | -1,048.13% |
| Apr 30, 2023 | -334.15% |
| Jan 31, 2023 | -210.91% |
| Oct 31, 2022 | -126.13% |
| Jul 31, 2022 | -106.66% |
| Apr 30, 2022 | -97.70% |
| Jan 31, 2022 | -78.01% |
| Oct 31, 2021 | -58.84% |
| Jul 31, 2021 | -70.24% |
| Apr 30, 2021 | -1,421.01% |
API Access
Alzamend Neuro Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();